• About
  • Services
  • Clients
  • Client News
  • PCG Research
  • PCG Digital
  • Contact
  • follow:

  • 19 Oct

    Exicure Announces Phase 1b Poster Presentation at The Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting

    Exicure, Inc. (NASDAQ: XCUR), the pioneer in gene regulatory and immunotherapeutic drugs utilizing proprietary spherical nucleic acid (SNA™) technology, announced an upcoming poster presentation for its intratumoral product candidate, cavrotolimod (AST-008), at the 35th Anniversary Annual Meeting of the Society for Immunotherapy of Cancer (SITC), to be held virtually from November… Read More..

    Share this:
  • 13 Apr

    Arch Therapeutics Receives CE Mark Approval for AC5™ Topical Hemostat in Europe

    Novel hemostatic wound dressing provides distinctive features FRAMINGHAM, Mass., April 13, 2020 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, today announced receipt of the CE (Conformité Européenne) mark for its first-in-class wound care… Read More..

    Share this:
  • 25 Jun

    PCG Advisory Launches New Corporate Website at PCGAdvisory.com

    New Website Offers More Comprehensive Understanding of PCG’s Value Proposition and Overall Client Benefits New York City, NY, June 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- PCG Advisory, Inc., a leading investor relations, strategic communications and cutting-edge digital marketing firm, today announced the launch of its new redesigned website,… Read More..

    Share this:
« Previous 1 … 238 239 240 241 242 … 253 Next »
  • Twitter feed is not available at the moment.
  • QUICK LINKS

    • About
    • Services
    • Clients
    • Client Media
    • PCG Media
    • PCG Research
    • Contact
    • Privacy Policy
    • Disclosures

    FOLLOW US

    Copyright © 2022 PCG Advisory.

    MENU logo
    • About
    • Services
    • Clients
    • Client News
    • PCG Research
    • PCG Digital
    • Contact